Gyeonggi-do
South Korea
7
2025-06-05
6
2023-02-28
These are the the leading inventors for applications assigned to OliX Pharmaceuticals. Inc.:
OliX Pharmaceuticals. Inc. based in Gyeonggi-do, KR has been assigned the rights to these inventions. The list includes both Pending Applications and Patent Grants:
RNAI AGENT TARGETING MARC1 GENE, AND USE THEREOF
#2 | 2021-09-16 ā Patent 11,591,600 granted on 2023-02-28Long double-stranded RNA for RNA interference
#3 | 2020-04-09 ā Patent 10,947,541 granted on 2021-03-16Treatment of atopic dermatitis and asthma using RNA complexes that target IL4RĪ±, TRPA1, or F2RL1
#4 | 2019-12-19 ā Patent 11,118,184 granted on 2021-09-14Asymmetric siRNA for inhibiting expression of male pattern hair loss target gene
#5 | 2019-12-05 ā Patent 10,829,761 granted on 2020-11-10Treatment of idiopathic pulmonary fibrosis using RNA complexes that target connective tissue growth factor
#6 | 2019-10-24 ā Patent 11,040,057 granted on 2021-06-22Pharmaceutical compositions and methods for potentiating gene silencing
#7 | 2019-06-13 ā Patent 10,829,760 granted on 2020-11-10Nucleic acid molecules inducing RNA interference, and uses thereof
Also check out OliX Pharmaceuticals, Inc.'s (Gyeonggi-do, South Korea) applicant profile with 6 patent applications submitted.
358796 ā